IMVT — IMMUNOVANT INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in IMMUNOVANT INC (IMVT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
6.12% (2023 Q4)
Avg. % of fund
3.95%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 288,677 -52,671 -15.4% 3.93% $7.3M $25.42
2025 Q3 ADDED 341,348 +328,901 +2642.4% 5.42% $5.5M $16.12
2024 Q3 REDUCED 12,447 -191,145 -93.9% 0.31% $355K $28.51
2023 Q4 INITIATED 203,592 — — 6.12% $8.6M —
% of Fund (quarterly)    IMVT price (monthly, adj. close)

Other funds also holding IMVT

As of 2025 Q4 — sorted by position size

Alpine Global Management, LLC 3Y 7Y 11.36% GREAT POINT PARTNERS LLC 3Y 7Y 6.18% Deep Track Capital, LP 3Y 5.22% ADAR1 Capital Management, LLC 4.57% STEMPOINT CAPITAL LP 2.81% Logos Global Management LP 3Y 2.11% Exome Asset Management LLC 1.93% ARMISTICE CAPITAL, LLC 3Y 7Y 1.74% Two Seas Capital LP 3Y 1.5% HighVista Strategies LLC 3Y 7Y 1.45%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings